Catecholamines may react with other molecules to produce catecholamine derivatives. For example, nitric oxide may induce nitration of dopamine to form 6-nitrodopamine (6-ND). The endogenous production of such a novel catecholamine has been demonstrated in the mammalian and reptilian cardiovascular system, and in vitro studies demonstrate that 6-ND relaxes pre-contracted aortic rings, and acts as a potent chronotropic agent. So far, however, the in vivo effects of 6-ND remain to be characterised in whole organisms. Using South American rattlesnakes (Crotalus durissus), we measured the endogenous production of 6-ND and other catecholamine derivatives in different tissues of the cardiovascular system and the intercostal muscle. We also used myography to measure the vascular reactivity of the mesenteric artery to 6-ND, and we utilised anaesthetised individuals to measure haemodynamic responses to bolus injections of 6-ND (1 μmol kg-1). Except for blood plasma, 6-ND was detected in all tissues studied, and the addition of l-NAME, a blocker of nitric oxide synthesis, did not alter the production of 6-ND, indicating there are alternative biosynthetic pathways. The isolated mesenteric artery contracted in the presence of adrenaline, dopamine, noradrenaline and 6-ND. We also observed a potentiation of the noradrenergic stimulation in the presence of 6-ND. Finally, injection of 6-ND elicited a small but significant reduction in the mesenteric conductance. It is likely that 6-ND per se exerts small effects on overall haemodynamics, but synergises with noradrenaline and possibly other catecholamines to enhance cardiovascular regulation.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: